MGMT Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas

JAMA Oncol. 2023 Dec 1;9(12):1734-1735. doi: 10.1001/jamaoncol.2023.4736.

Binghao Zhao^{1

2

3}, Hao Qi¹, Wenbin Ma^{2

3}

¹ DKTK Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
² Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
³ State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.

No abstract available

MeSH terms